CD4 and AIDS: None of the lesions described is exclusive to HIV/AIDS patients; however, all of them present higher prevalence, severity, and progression in comparison to HIV-negative patients, especially in low CD4+ T lymphocyte counts and, in some cases, associated with the use of ART.